Skip to main content

Table 8 Lack of association between the baseline DS3 bone domain score and composite attainment of therapeutic goals

From: Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes

Therapeutic goals attained

Number of patients

Mean DS3 score (SD)

95% Confidence interval

ANOVA P value

Intact spleen pts (N = 45)

   

0.508

6 of 6

14

2.70 (1.60)

1.86--3.54

 

5 of 6

21

3.01 (1.71)

2.28--3.74

 

4 of 6

10

2.23 (1.97)

1.01--4.20

 

Splenectomy pts (N = 15)

   

0.282

5 of 5

6

4.26 (2.33)

2.40--6.12

 

4 of 5

5

5.82 (1.03)

4.92--6.72

 

3 of 5

3

6.08 (1.28)

4.63--7.53

Â